Prothrombin Complex Concentrate Market Size, Global Industry Growth, Forecast 2024–2032
The global prothrombin complex concentrate (PCC) market, valued at USD 695.3 million in 2019, is anticipated to reach USD 2,385.3 million by 2032, with a CAGR of 9.6%.
Fortune Business Insights has added the Latest Report on the “ Prothrombin Complex Concentrate Market” The Research Report mainly includes Size, Share, Growth Factors, Sales, Demand, Revenue, Trade, Forecast and Global companies Analysis. To offer more clarity regarding the industry, the report takes a closer look at the current status of various factors including but not limited to supply chain management, niche markets, distribution channel, trade, supply, and demand and production capability across different countries.
The market examines developments, product launches, acquisitions, mergers, joint ventures, market competitive research, key players, and brands. The market document also reviews important players, significant partnerships, mergers and acquisitions, and trending developments.
Request a Free Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/100102
Global Prothrombin Complex Concentrate Market from 2024 to 2032, published by Fortune Business Insights, is a trusted source of data and information that provides a thorough perspective of the industry’s condition and current market trends, situations, and opportunities.
The analysis offers data on industry trends and developments, market dynamics, drivers, and capacity. The study enables the industry expert to keep up with the most recent trends and sector performance where they can predict a sharp decline in market share between 2024 and 2032. An important purpose of the report is to provide a thorough analysis of the market with insightful views, details, actual data, and data verified by the industry.
Key Segments and leading prominent companies profiled Included in the Report are:
- Grifols, S.A. (Spain)
- CSL Behring (U.S.)
- Octopharma AG (Switzerland)
- Sanquin (Netherlands)
- Kedrion S.p.A (Italy)
- China Biologic Products Holdings, Inc. (China)
- Takeda Pharmaceutical Company Limited (Japan)
- Others
Market Drivers:
Increasing Prevalence of Hemophilia to Augment Market Growth
Hemophilia is a rare bleeding disorder that is characterized by the deficiency of blood-clotting proteins in a person. A study conducted by a team of international researchers, spearheaded by the McMaster University in Canada, found that over 1,125,000 men suffer from inherited hemophilia, which is three times higher than previously believed. Of these, approximately 418,000 are afflicted with the more severe variant of the disease, with the highest incidence of the disorder being observed in middle- and low-income countries.
This bodes well for the PCC market growth as the demand for plasma-derived factor IX, a vital blood clotting factor in hemophilia B patients, is steadily rising. For example, the World Federation of Hemophilia reported that more than 68,703,141 I.
Unit plasma-derived factor IX was used in Europe in 2018. These developments are expected to favor the growth of the prothrombin complex concentrate market in the future.
Market Segment Analysis:
The study conducts a SWOT analysis of each company to evaluate strengths and weaknesses. It also evaluates the trends observed in the parent market, along with the macroeconomic indicators, prevailing factors, and market appeal according to different segments. The report also predicts the influence of different industry aspects on the Raisins market segments and regions.
Segmentation:
By Product Type
3-factor
4-factor
By Application
Acquired Coagulation Factor Deficiency
Congenital Coagulation Factor Deficiency
By End User
Hospital & Ambulatory Surgical Centers
Specialty Clinics
Others
Speak to Our Analyst: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/100102
The report covers extensive competitive intelligence which includes the following data points:
✔ Business Overview
✔ Business Model
✔ Financial Data
✔ Financial — Existing
✔ Financial — Funding
✔ Product/Service Segment Analysis and specification
✔ Recent Development and Company Strategy Analysis
✔ SWOT Analysis
Key Benefits for Stakeholders:
- The study represents a quantitative analysis of the present Prothrombin Complex Concentrate Market trends, estimations, and dynamics of the market size from 2024 to 2032 to determine the most promising opportunities.
- Porter’s five forces study emphasizes the importance of buyers and suppliers in assisting stakeholders to make profitable business decisions and expand their supplier-buyer network.
- In-depth analysis, as well as market size and segmentation, help you identify current Prothrombin Complex Concentrate Market opportunities.
- The largest countries in each region are mapped according to their revenue contribution to the market.
- The Prothrombin Complex Concentrate Market research report gives a thorough analysis of the current status of the major players.
Important regions covered in the Prothrombin Complex Concentrate Market report include:
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Order a copy of this research report at — https://www.fortunebusinessinsights.com/checkout-page/100102
RELATED REPORTS:
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
Email: sales@fortunebusinessinsights.com
Phone: US: +1 424 253 0390, UK: +44 2071 939123, APAC: +91 74